BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16968465)

  • 1. Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
    Pizzolo F; Friso S; Olivieri O; Martinelli N; Bozzini C; Guarini P; Trabetti E; Faccini G; Corrocher R; Girelli D
    Eur J Clin Invest; 2006 Oct; 36(10):698-704. PubMed ID: 16968465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
    Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
    Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
    Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease.
    Bowron A; Scott J; Stansbie D
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):459-62. PubMed ID: 16259797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians.
    Vinukonda G; Shaik Mohammad N; Md Nurul Jain J; Prasad Chintakindi K; Rama Devi Akella R
    Clin Chim Acta; 2009 Jul; 405(1-2):127-31. PubMed ID: 19394322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants and associations of homocysteine and prothrombotic risk factors in Kuwaiti patients with cerebrovascular accident.
    Mojiminiyi OA; Marouf R; Al Shayeb AR; Qurtom M; Abdella NA; Al Wazzan H; Al Humood S; Samad MA; El-Muzaini H
    Med Princ Pract; 2008; 17(2):136-42. PubMed ID: 18287798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of total homocysteine plasma concentration in type 2 diabetes.
    Russo GT; Di Benedetto A; Giorda C; Alessi E; Crisafulli G; Ientile R; Di Cesare E; Jacques PF; Raimondo G; Cucinotta D
    Eur J Clin Invest; 2004 Mar; 34(3):197-204. PubMed ID: 15025678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
    Fridman O; Porcile R; Vanasco V; Junco MN; Gariglio L; Potenzoni MA; Bañes I; Morales A
    Clin Exp Hypertens; 2008 Oct; 30(7):574-84. PubMed ID: 18855261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
    Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
    Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperhomocystinemia and 677C T methylenetetrahydrofolate reductase polymorphism as a cardiovascular risk factor in childhood].
    Mainou Cid C; García Giralt N; Vilaseca Buscà MA; Ferrer Codina I; Meco López JF; Mainou Pintó A; Pintó Sala X; Grinberg Vaisman D; Balcells Comas S
    An Esp Pediatr; 2002 May; 56(5):402-8. PubMed ID: 12042167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease.
    Gupta M; Sharma P; Garg G; Kaur K; Bedi GK; Vij A
    Clin Chim Acta; 2005 Feb; 352(1-2):121-5. PubMed ID: 15653106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.